വൻകുടൽ കാൻസർ ചികിത്സയുടെ വിശദാംശങ്ങൾ വെളിപ്പെടുത്തുന്നു- ഭാഗം 4

Let's delve deeper into this topic. In Stage 2 cancer, we can distinguish between high-risk and low-risk cases based on various factors. For those deemed low-risk, chemotherapy may not be necessary, while high-risk patients often receive chemotherapy.
Now, when it comes to Stage 4 cancer, a more comprehensive evaluation is crucial before deciding on chemotherapy. This involves molecular tests, MSI tests, Her2 tests, assessing the patient's overall health, DPYD tests, and more.
Additionally, there's a minimally invasive technique known as Radiofrequency Ablation (RFA) that plays a pivotal role in reducing the size of tumors, nodules, or growths within the body.
In cases of Stage 4 cancer with high MSI, Immunotherapy emerges as a potential treatment option. It's worth noting that for some MSI-high patients, Immunotherapy can effectively combat cancer without the need for surgery, even if it has metastasized to other organs.
As you can see, determining the right treatment path for colon cancer involves a complex interplay of factors. We hope this video has provided you with valuable insights. Thank you for tuning in.